TITLE 68: PROFESSIONS AND OCCUPATIONS
CHAPTER VII: DEPARTMENT OF FINANCIAL AND PROFESSIONAL REGULATION
SUBCHAPTER b: PROFESSIONS AND OCCUPATIONS
PART 1370 BOXING AND FULL-CONTACT MARTIAL ARTS ACT
SECTION 1370.220 ADMINISTRATION OR USE OF DRUGS


 

Section 1370.220  Administration or Use of Drugs

 

a)         The administration or use of any drugs, alcohol or stimulants, or injections in any part of the body or applied topically to any part of the body, either before or during a bout, to or by any contestant is prohibited.  Any contestant violating this Section shall be subject to disqualification or other disciplinary or non-disciplinary action the Division deems proper.

 

b)         The Division may request, at any time, that a contestant submit to a drug screen at the contestant's expense when the test is ordered for a permitted contest. 

 

c)         A person who applies for or holds a license as a professional contestant and who has at any time had a positive drug test confirmed by any state, tribal athletic commission, territory, federal agency or county that regulates contests in another jurisdiction for any substance described in subsection (c) shall be required as a condition of licensure or renewal to provide a urine specimen. In addition, contestants shall provide a urine specimen for drug testing either before or after the bout, as directed by the Division representative.

 

d)         A positive test for any of the following substances shall be conclusive evidence of a violation of subsection (a):

 

1)         Stimulants

 

2)         Narcotics

 

3)         Cannabinoids (marijuana)

 

4)         Anabolic agents (exogenous and endogenous)

 

5)         Peptide hormones

 

6)         Masking agents

 

7)         Diuretics

 

8)         Glucocorticosteroids

 

9)         Beta-2 agonists (asthma medications) except salbutamol (maximum 1600 micrograms over 24 hours) and salmeterol by inhalation

 

10)        Anti-estrogenic agents

 

11)         Alcohol

 

12)         Any drug identified on the Prohibited List published by the World Anti-Doping Agency (2012), which is hereby incorporated by reference. The most current edition of the Prohibited List may be obtained, free of charge, from the World Anti-Doping Agency, Stock Exchange Tower, 800 Place Victoria, Suite 1700, PO Box 120, Montreal, Quebec, Canada, H4Z 1B7 or at www.wada-ama.org. This incorporation includes no later editions or amendments.